Examination of reliability and validity of Japanese version CADS

Examination of reliability and validity of Japanese version CADS - Examination of reliability and validity of Japanese version CADS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044365

Enrollment

129

Registered

2021-06-01

Start date

2021-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients with breast cancer who are over 20 years old and agreed with informed consent. Patients who are performed perioperative chemotherapy including anthracycline or taxane. Patients with chemotherapy-induced alopecia.

Exclusion criteria

Exclusion criteria: Patients who have a history of chemotherapy-induced alopecia before. Patients who are thought to be incompatible to join this study.

Design outcomes

Primary

Measure	Time frame
Psychometric validity and reliability of Japanese version of CADS	—

Countries

Japan

Contacts

Public ContactYosuke Aoyama

Toranomon Hospital Department of Medical Oncology

yosuke.aoyama10@gmail.com03-3588-1111

Outcome results